tetano
Editor, Senior Moderator
Front Med
. 2021 Apr 16.
doi: 10.1007/s11684-020-0814-5. Online ahead of print.
Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic
William J Liu[SUP] 1 2 [/SUP], Haixia Xiao[SUP] 3 [/SUP], Lianpan Dai[SUP] 4 [/SUP], Di Liu[SUP] 5 6 7 8 [/SUP], Jianjun Chen[SUP] 5 6 7 8 [/SUP], Xiaopeng Qi[SUP] 9 [/SUP], Yuhai Bi[SUP] 10 4 7 8 [/SUP], Yi Shi[SUP] 10 4 7 8 [/SUP], George F Gao[SUP] 11 4 9 [/SUP], Yingxia Liu[SUP] 12 [/SUP]
Affiliations
Abstract
The avian influenza A (H7N9) virus is a zoonotic virus that is closely associated with live poultry markets. It has caused infections in humans in China since 2013. Five waves of the H7N9 influenza epidemic occurred in China between March 2013 and September 2017. H7N9 with low-pathogenicity dominated in the first four waves, whereas highly pathogenic H7N9 influenza emerged in poultry and spread to humans during the fifth wave, causing wide concern. Specialists and officials from China and other countries responded quickly, controlled the epidemic well thus far, and characterized the virus by using new technologies and surveillance tools that were made possible by their preparedness efforts. Here, we review the characteristics of the H7N9 viruses that were identified while controlling the spread of the disease. It was summarized and discussed from the perspectives of molecular epidemiology, clinical features, virulence and pathogenesis, receptor binding, T-cell responses, monoclonal antibody development, vaccine development, and disease burden. These data provide tools for minimizing the future threat of H7N9 and other emerging and re-emerging viruses, such as SARS-CoV-2.
Keywords: H7N9; HPAIV; clinical features; epidemiology; hemagglutinin; immunity; pathogenesis; vaccine.
. 2021 Apr 16.
doi: 10.1007/s11684-020-0814-5. Online ahead of print.
Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic
William J Liu[SUP] 1 2 [/SUP], Haixia Xiao[SUP] 3 [/SUP], Lianpan Dai[SUP] 4 [/SUP], Di Liu[SUP] 5 6 7 8 [/SUP], Jianjun Chen[SUP] 5 6 7 8 [/SUP], Xiaopeng Qi[SUP] 9 [/SUP], Yuhai Bi[SUP] 10 4 7 8 [/SUP], Yi Shi[SUP] 10 4 7 8 [/SUP], George F Gao[SUP] 11 4 9 [/SUP], Yingxia Liu[SUP] 12 [/SUP]
Affiliations
- PMID: 33860875
- DOI: 10.1007/s11684-020-0814-5
Abstract
The avian influenza A (H7N9) virus is a zoonotic virus that is closely associated with live poultry markets. It has caused infections in humans in China since 2013. Five waves of the H7N9 influenza epidemic occurred in China between March 2013 and September 2017. H7N9 with low-pathogenicity dominated in the first four waves, whereas highly pathogenic H7N9 influenza emerged in poultry and spread to humans during the fifth wave, causing wide concern. Specialists and officials from China and other countries responded quickly, controlled the epidemic well thus far, and characterized the virus by using new technologies and surveillance tools that were made possible by their preparedness efforts. Here, we review the characteristics of the H7N9 viruses that were identified while controlling the spread of the disease. It was summarized and discussed from the perspectives of molecular epidemiology, clinical features, virulence and pathogenesis, receptor binding, T-cell responses, monoclonal antibody development, vaccine development, and disease burden. These data provide tools for minimizing the future threat of H7N9 and other emerging and re-emerging viruses, such as SARS-CoV-2.
Keywords: H7N9; HPAIV; clinical features; epidemiology; hemagglutinin; immunity; pathogenesis; vaccine.